In lung adenocarcinoma, TUBA1C has been identified as a robust prognostic biomarker associated with the abundance of immune cell infiltration (15).Additionally, TUBA1C promotes the progression of bladder cancer via the regulation of the cell cycle (16), and accelerates the progression of gastric cancer by activating the PI3K/AKT and cell cycle-related pathways (17). This evidence concerns the gene TUBA1C and urinary bladder cancer.